Elutia Inc. (AZYO)

1.4900 +0.0300 (+2.05%) As of 03:59PM EDT. Market open.

Elutia Inc.

12510 Prosperity Drive
Suite 370
Silver Spring, MD 20904
United States
240 247 1170
https://www.aziyo.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 151

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Kevin L. Rakin M.B.A, M.S.	Exec. Chairman	142.1k	N/A	1961
Dr. C. Randal Mills Ph.D.	Co-Founder, Pres & CEO and Director	857.26k	N/A	1972
Mr. Matthew B. Ferguson	Chief Financial Officer	360.65k	N/A	1968
Mr. Thomas Englese	Advisor	409.55k	N/A	1974
Ms. Erica Elchin	VP of Global Operations	N/A	N/A	N/A
Dr. Michelle LeRoux Williams Ph.D.	Chief Scientific Officer	N/A	N/A	1975
Ms. Courtney Guyer	VP of Marketing	N/A	N/A	N/A
Dr. Sonali Fonseca Ph.D.	Head of Emerging Bus.es	N/A	N/A	N/A
Mr. Jeffry D. Hamet	Sr. VP of Fin., Treasurer & Sec.	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative products to address the device protection, women's health, orthobiologics, cardiovascular, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

Corporate governance

Elutia Inc.’s ISS governance QualityScore as of 1 September 2023 is 8. The pillar scores are Audit: 3; Board: 10; Shareholder rights: 8; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.